Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage
Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in elderly patients. Growing evidence suggests a potential role of aquaporin 4 (AQP4) in amyloid-beta-associated diseases, including CAA pathology. Our aim was to investigate the circulating levels of AQP4 in...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/5/989 |
id |
doaj-d7ced31b16e942579a4c22a7ac4a3261 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Paula Marazuela Anna Bonaterra-Pastra Júlia Faura Anna Penalba Jesús Pizarro Olalla Pancorbo David Rodríguez-Luna Carla Vert Alex Rovira Francesc Pujadas M. Mar Freijo Silvia Tur Maite Martínez-Zabaleta Pere Cardona Portela Rocío Vera Lucia Lebrato-Hernández Juan F. Arenillas Soledad Pérez-Sánchez Joan Montaner Pilar Delgado Mar Hernández-Guillamon |
spellingShingle |
Paula Marazuela Anna Bonaterra-Pastra Júlia Faura Anna Penalba Jesús Pizarro Olalla Pancorbo David Rodríguez-Luna Carla Vert Alex Rovira Francesc Pujadas M. Mar Freijo Silvia Tur Maite Martínez-Zabaleta Pere Cardona Portela Rocío Vera Lucia Lebrato-Hernández Juan F. Arenillas Soledad Pérez-Sánchez Joan Montaner Pilar Delgado Mar Hernández-Guillamon Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage Journal of Clinical Medicine aquaporin 4 cerebral amyloid angiopathy intracerebral hemorrhage magnetic resonance imaging markers functional outcome |
author_facet |
Paula Marazuela Anna Bonaterra-Pastra Júlia Faura Anna Penalba Jesús Pizarro Olalla Pancorbo David Rodríguez-Luna Carla Vert Alex Rovira Francesc Pujadas M. Mar Freijo Silvia Tur Maite Martínez-Zabaleta Pere Cardona Portela Rocío Vera Lucia Lebrato-Hernández Juan F. Arenillas Soledad Pérez-Sánchez Joan Montaner Pilar Delgado Mar Hernández-Guillamon |
author_sort |
Paula Marazuela |
title |
Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage |
title_short |
Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage |
title_full |
Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage |
title_fullStr |
Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage |
title_full_unstemmed |
Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage |
title_sort |
circulating aqp4 levels in patients with cerebral amyloid angiopathy-associated intracerebral hemorrhage |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2021-03-01 |
description |
Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in elderly patients. Growing evidence suggests a potential role of aquaporin 4 (AQP4) in amyloid-beta-associated diseases, including CAA pathology. Our aim was to investigate the circulating levels of AQP4 in a cohort of patients who had suffered a lobar ICH with a clinical diagnosis of CAA. AQP4 levels were analyzed in the serum of 60 CAA-related ICH patients and 19 non-stroke subjects by enzyme-linked immunosorbent assay (ELISA). The CAA–ICH cohort was divided according to the time point of the functional outcome evaluation: mid-term (12 ± 18.6 months) and long-term (38.5 ± 32.9 months) after the last ICH. Although no differences were found in AQP4 serum levels between cases and controls, lower levels were found in CAA patients presenting specific hemorrhagic features such as ≥2 lobar ICHs and ≥5 lobar microbleeds detected by magnetic resonance imaging (MRI). In addition, CAA-related ICH patients who presented a long-term good functional outcome had higher circulating AQP4 levels than subjects with a poor outcome or controls. Our data suggest that AQP4 could potentially predict a long-term functional outcome and may play a protective role after a lobar ICH. |
topic |
aquaporin 4 cerebral amyloid angiopathy intracerebral hemorrhage magnetic resonance imaging markers functional outcome |
url |
https://www.mdpi.com/2077-0383/10/5/989 |
work_keys_str_mv |
AT paulamarazuela circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT annabonaterrapastra circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT juliafaura circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT annapenalba circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT jesuspizarro circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT olallapancorbo circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT davidrodriguezluna circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT carlavert circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT alexrovira circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT francescpujadas circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT mmarfreijo circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT silviatur circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT maitemartinezzabaleta circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT perecardonaportela circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT rociovera circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT lucialebratohernandez circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT juanfarenillas circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT soledadperezsanchez circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT joanmontaner circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT pilardelgado circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage AT marhernandezguillamon circulatingaqp4levelsinpatientswithcerebralamyloidangiopathyassociatedintracerebralhemorrhage |
_version_ |
1724234024873885696 |
spelling |
doaj-d7ced31b16e942579a4c22a7ac4a32612021-03-03T00:00:27ZengMDPI AGJournal of Clinical Medicine2077-03832021-03-011098998910.3390/jcm10050989Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral HemorrhagePaula Marazuela0Anna Bonaterra-Pastra1Júlia Faura2Anna Penalba3Jesús Pizarro4Olalla Pancorbo5David Rodríguez-Luna6Carla Vert7Alex Rovira8Francesc Pujadas9M. Mar Freijo10Silvia Tur11Maite Martínez-Zabaleta12Pere Cardona Portela13Rocío Vera14Lucia Lebrato-Hernández15Juan F. Arenillas16Soledad Pérez-Sánchez17Joan Montaner18Pilar Delgado19Mar Hernández-Guillamon20Neurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainStroke Unit, Department of Neurology, Vall d’Hebron Hospital, 08035 Barcelona, SpainStroke Unit, Department of Neurology, Vall d’Hebron Hospital, 08035 Barcelona, SpainNeuroradiology, Department of Radiology, Vall d’Hebron Hospital, 08035 Barcelona, SpainNeuroradiology, Department of Radiology, Vall d’Hebron Hospital, 08035 Barcelona, SpainDementia Unit, Neurology Department, Vall d’Hebron Hospital, 08035 Barcelona, SpainNeurovascular Group, Biocruces Health Research Institute, 48903 Barakaldo, SpainNeurology, Son Espases University Hospital, 07120 Balearic Islands, SpainDepartment of Neurology, Donostia University Hospital, 20080 San Sebastián, SpainDepartment of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, 08907 Barcelona, SpainStroke Unit, Department of Neurology, Ramon y Cajal University Hospital, 28034 Madrid, SpainStroke Unit, Virgen del Rocío University Hospital, 41013 Sevilla, SpainStroke Program, Department of Neurology, Hospital Clínico Universitario, 47003 Valladolid, SpainDepartment of Neurology, Virgen Macarena University Hospital, 41009 Sevilla, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainNeurovascular Research Laboratory, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainCerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in elderly patients. Growing evidence suggests a potential role of aquaporin 4 (AQP4) in amyloid-beta-associated diseases, including CAA pathology. Our aim was to investigate the circulating levels of AQP4 in a cohort of patients who had suffered a lobar ICH with a clinical diagnosis of CAA. AQP4 levels were analyzed in the serum of 60 CAA-related ICH patients and 19 non-stroke subjects by enzyme-linked immunosorbent assay (ELISA). The CAA–ICH cohort was divided according to the time point of the functional outcome evaluation: mid-term (12 ± 18.6 months) and long-term (38.5 ± 32.9 months) after the last ICH. Although no differences were found in AQP4 serum levels between cases and controls, lower levels were found in CAA patients presenting specific hemorrhagic features such as ≥2 lobar ICHs and ≥5 lobar microbleeds detected by magnetic resonance imaging (MRI). In addition, CAA-related ICH patients who presented a long-term good functional outcome had higher circulating AQP4 levels than subjects with a poor outcome or controls. Our data suggest that AQP4 could potentially predict a long-term functional outcome and may play a protective role after a lobar ICH.https://www.mdpi.com/2077-0383/10/5/989aquaporin 4cerebral amyloid angiopathyintracerebral hemorrhagemagnetic resonance imaging markersfunctional outcome |